Umang Swami

53PUBLICATIONS
233CO-AUTHORS
Radiation therapyPredictive and prognostic markersMedical genetics (excl. cancer genetics)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jun 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk.

|Apr 01, 2026
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab.

Georges Gebrael, Yeonjung Jo, Zeynep Irem Ozay

|Feb 10, 2026
Corticosteroid Use and Risk of Adverse Events in Metastatic Hormone-Sensitive Prostate Cancer.

Umang Swami, Qiujun Shao, Tamuno Alfred

Pageof 9

Frequent Collaborators

24 joint publications

Neeraj Agarwal

12 joint publications

Nicolas Sayegh

5 joint publications

Kamal Kant Sahu

5 joint publications

Georges Gebrael